Global Anti-Rheumatic Drugs Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Anti-rheumatic drugs are medications used to treat rheumatic diseases, which are conditions characterized by inflammation, pain, stiffness, and swelling in the joints, muscles, and other connective tissues. Rheumatic diseases encompass a wide range of conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus (SLE), and juvenile idiopathic arthritis, among others. The goals of treatment with anti-rheumatic drugs are to reduce inflammation, alleviate symptoms, prevent disease progression, and improve overall quality of life for patients.
The global Anti-Rheumatic Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Anti-Rheumatic Drugs Industry Forecast” looks at past sales and reviews total world Anti-Rheumatic Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-Rheumatic Drugs sales for 2023 through 2029. With Anti-Rheumatic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Rheumatic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-Rheumatic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anti-Rheumatic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-Rheumatic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Rheumatic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Rheumatic Drugs.
United States market for Anti-Rheumatic Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Anti-Rheumatic Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Anti-Rheumatic Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Anti-Rheumatic Drugs players cover Novartis, UCB, AbbVie, Bristol-Myers Squibb, Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Rheumatic Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
Anti-rheumatic drugs are medications used to treat rheumatic diseases, which are conditions characterized by inflammation, pain, stiffness, and swelling in the joints, muscles, and other connective tissues. Rheumatic diseases encompass a wide range of conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus (SLE), and juvenile idiopathic arthritis, among others. The goals of treatment with anti-rheumatic drugs are to reduce inflammation, alleviate symptoms, prevent disease progression, and improve overall quality of life for patients.
The global Anti-Rheumatic Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Anti-Rheumatic Drugs Industry Forecast” looks at past sales and reviews total world Anti-Rheumatic Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-Rheumatic Drugs sales for 2023 through 2029. With Anti-Rheumatic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Rheumatic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-Rheumatic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anti-Rheumatic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-Rheumatic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Rheumatic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Rheumatic Drugs.
United States market for Anti-Rheumatic Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Anti-Rheumatic Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Anti-Rheumatic Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Anti-Rheumatic Drugs players cover Novartis, UCB, AbbVie, Bristol-Myers Squibb, Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Rheumatic Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Disease Modifying Anti-rheumatics Drugs (DMARD's)
- Nonsteroidal Anti-inflammatory Drugs (NSAID's)
- Corticosteroids
- Uric Acid Drugs
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Disease Modifying Anti-rheumatics Drugs (DMARD's)
- Nonsteroidal Anti-inflammatory Drugs (NSAID's)
- Corticosteroids
- Uric Acid Drugs
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- UCB
- AbbVie
- Bristol-Myers Squibb
- Merck
- HEYL Chemisch-pharmazeutische Fabrik
- Roche
- Johnson & Johnson
- Amgen
- Pfizer
- GSK
- Sanofi
- Abbott Laboratories
- Teva Pharmaceutical
- Eli Lilly and Company
- Celltrion
- Astellas Pharma
- Simcere
- Daiichi Sankyo
- Asahi Kasei
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Rheumatic Drugs Market Size 2019-2030
2.1.2 Anti-Rheumatic Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Anti-Rheumatic Drugs by Country/Region, 2019, 2023 & 2030
2.2 Anti-Rheumatic Drugs Segment by Type
2.2.1 Disease Modifying Anti-rheumatics Drugs (DMARD's)
2.2.2 Nonsteroidal Anti-inflammatory Drugs (NSAID's)
2.2.3 Corticosteroids
2.2.4 Uric Acid Drugs
2.2.5 Others
2.3 Anti-Rheumatic Drugs Market Size by Type
2.3.1 Anti-Rheumatic Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Anti-Rheumatic Drugs Market Size Market Share by Type (2019-2024)
2.4 Anti-Rheumatic Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Anti-Rheumatic Drugs Market Size by Application
2.5.1 Anti-Rheumatic Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Anti-Rheumatic Drugs Market Size Market Share by Application (2019-2024)
3 ANTI-RHEUMATIC DRUGS MARKET SIZE BY PLAYER
3.1 Anti-Rheumatic Drugs Market Size Market Share by Player
3.1.1 Global Anti-Rheumatic Drugs Revenue by Player (2019-2024)
3.1.2 Global Anti-Rheumatic Drugs Revenue Market Share by Player (2019-2024)
3.2 Global Anti-Rheumatic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTI-RHEUMATIC DRUGS BY REGION
4.1 Anti-Rheumatic Drugs Market Size by Region (2019-2024)
4.2 Global Anti-Rheumatic Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Anti-Rheumatic Drugs Market Size Growth (2019-2024)
4.4 APAC Anti-Rheumatic Drugs Market Size Growth (2019-2024)
4.5 Europe Anti-Rheumatic Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa Anti-Rheumatic Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Anti-Rheumatic Drugs Market Size by Country (2019-2024)
5.2 Americas Anti-Rheumatic Drugs Market Size by Type (2019-2024)
5.3 Americas Anti-Rheumatic Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Rheumatic Drugs Market Size by Region (2019-2024)
6.2 APAC Anti-Rheumatic Drugs Market Size by Type (2019-2024)
6.3 APAC Anti-Rheumatic Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Anti-Rheumatic Drugs Market Size by Country (2019-2024)
7.2 Europe Anti-Rheumatic Drugs Market Size by Type (2019-2024)
7.3 Europe Anti-Rheumatic Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Rheumatic Drugs by Region (2019-2024)
8.2 Middle East & Africa Anti-Rheumatic Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Anti-Rheumatic Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTI-RHEUMATIC DRUGS MARKET FORECAST
10.1 Global Anti-Rheumatic Drugs Forecast by Region (2025-2030)
10.1.1 Global Anti-Rheumatic Drugs Forecast by Region (2025-2030)
10.1.2 Americas Anti-Rheumatic Drugs Forecast
10.1.3 APAC Anti-Rheumatic Drugs Forecast
10.1.4 Europe Anti-Rheumatic Drugs Forecast
10.1.5 Middle East & Africa Anti-Rheumatic Drugs Forecast
10.2 Americas Anti-Rheumatic Drugs Forecast by Country (2025-2030)
10.2.1 United States Market Anti-Rheumatic Drugs Forecast
10.2.2 Canada Market Anti-Rheumatic Drugs Forecast
10.2.3 Mexico Market Anti-Rheumatic Drugs Forecast
10.2.4 Brazil Market Anti-Rheumatic Drugs Forecast
10.3 APAC Anti-Rheumatic Drugs Forecast by Region (2025-2030)
10.3.1 China Anti-Rheumatic Drugs Market Forecast
10.3.2 Japan Market Anti-Rheumatic Drugs Forecast
10.3.3 Korea Market Anti-Rheumatic Drugs Forecast
10.3.4 Southeast Asia Market Anti-Rheumatic Drugs Forecast
10.3.5 India Market Anti-Rheumatic Drugs Forecast
10.3.6 Australia Market Anti-Rheumatic Drugs Forecast
10.4 Europe Anti-Rheumatic Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market Anti-Rheumatic Drugs Forecast
10.4.2 France Market Anti-Rheumatic Drugs Forecast
10.4.3 UK Market Anti-Rheumatic Drugs Forecast
10.4.4 Italy Market Anti-Rheumatic Drugs Forecast
10.4.5 Russia Market Anti-Rheumatic Drugs Forecast
10.5 Middle East & Africa Anti-Rheumatic Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market Anti-Rheumatic Drugs Forecast
10.5.2 South Africa Market Anti-Rheumatic Drugs Forecast
10.5.3 Israel Market Anti-Rheumatic Drugs Forecast
10.5.4 Turkey Market Anti-Rheumatic Drugs Forecast
10.6 Global Anti-Rheumatic Drugs Forecast by Type (2025-2030)
10.7 Global Anti-Rheumatic Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Anti-Rheumatic Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Anti-Rheumatic Drugs Product Offered
11.1.3 Novartis Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 UCB
11.2.1 UCB Company Information
11.2.2 UCB Anti-Rheumatic Drugs Product Offered
11.2.3 UCB Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 UCB Main Business Overview
11.2.5 UCB Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Anti-Rheumatic Drugs Product Offered
11.3.3 AbbVie Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Anti-Rheumatic Drugs Product Offered
11.4.3 Bristol-Myers Squibb Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Anti-Rheumatic Drugs Product Offered
11.5.3 Merck Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 HEYL Chemisch-pharmazeutische Fabrik
11.6.1 HEYL Chemisch-pharmazeutische Fabrik Company Information
11.6.2 HEYL Chemisch-pharmazeutische Fabrik Anti-Rheumatic Drugs Product Offered
11.6.3 HEYL Chemisch-pharmazeutische Fabrik Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 HEYL Chemisch-pharmazeutische Fabrik Main Business Overview
11.6.5 HEYL Chemisch-pharmazeutische Fabrik Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Anti-Rheumatic Drugs Product Offered
11.7.3 Roche Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Information
11.8.2 Johnson & Johnson Anti-Rheumatic Drugs Product Offered
11.8.3 Johnson & Johnson Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Johnson & Johnson Main Business Overview
11.8.5 Johnson & Johnson Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Anti-Rheumatic Drugs Product Offered
11.9.3 Amgen Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Anti-Rheumatic Drugs Product Offered
11.10.3 Pfizer Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 GSK
11.11.1 GSK Company Information
11.11.2 GSK Anti-Rheumatic Drugs Product Offered
11.11.3 GSK Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 GSK Main Business Overview
11.11.5 GSK Latest Developments
11.12 Sanofi
11.12.1 Sanofi Company Information
11.12.2 Sanofi Anti-Rheumatic Drugs Product Offered
11.12.3 Sanofi Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Sanofi Main Business Overview
11.12.5 Sanofi Latest Developments
11.13 Abbott Laboratories
11.13.1 Abbott Laboratories Company Information
11.13.2 Abbott Laboratories Anti-Rheumatic Drugs Product Offered
11.13.3 Abbott Laboratories Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Abbott Laboratories Main Business Overview
11.13.5 Abbott Laboratories Latest Developments
11.14 Teva Pharmaceutical
11.14.1 Teva Pharmaceutical Company Information
11.14.2 Teva Pharmaceutical Anti-Rheumatic Drugs Product Offered
11.14.3 Teva Pharmaceutical Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Teva Pharmaceutical Main Business Overview
11.14.5 Teva Pharmaceutical Latest Developments
11.15 Eli Lilly and Company
11.15.1 Eli Lilly and Company Company Information
11.15.2 Eli Lilly and Company Anti-Rheumatic Drugs Product Offered
11.15.3 Eli Lilly and Company Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Eli Lilly and Company Main Business Overview
11.15.5 Eli Lilly and Company Latest Developments
11.16 Celltrion
11.16.1 Celltrion Company Information
11.16.2 Celltrion Anti-Rheumatic Drugs Product Offered
11.16.3 Celltrion Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Celltrion Main Business Overview
11.16.5 Celltrion Latest Developments
11.17 Astellas Pharma
11.17.1 Astellas Pharma Company Information
11.17.2 Astellas Pharma Anti-Rheumatic Drugs Product Offered
11.17.3 Astellas Pharma Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Astellas Pharma Main Business Overview
11.17.5 Astellas Pharma Latest Developments
11.18 Simcere
11.18.1 Simcere Company Information
11.18.2 Simcere Anti-Rheumatic Drugs Product Offered
11.18.3 Simcere Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Simcere Main Business Overview
11.18.5 Simcere Latest Developments
11.19 Daiichi Sankyo
11.19.1 Daiichi Sankyo Company Information
11.19.2 Daiichi Sankyo Anti-Rheumatic Drugs Product Offered
11.19.3 Daiichi Sankyo Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Daiichi Sankyo Main Business Overview
11.19.5 Daiichi Sankyo Latest Developments
11.20 Asahi Kasei
11.20.1 Asahi Kasei Company Information
11.20.2 Asahi Kasei Anti-Rheumatic Drugs Product Offered
11.20.3 Asahi Kasei Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Asahi Kasei Main Business Overview
11.20.5 Asahi Kasei Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Rheumatic Drugs Market Size 2019-2030
2.1.2 Anti-Rheumatic Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Anti-Rheumatic Drugs by Country/Region, 2019, 2023 & 2030
2.2 Anti-Rheumatic Drugs Segment by Type
2.2.1 Disease Modifying Anti-rheumatics Drugs (DMARD's)
2.2.2 Nonsteroidal Anti-inflammatory Drugs (NSAID's)
2.2.3 Corticosteroids
2.2.4 Uric Acid Drugs
2.2.5 Others
2.3 Anti-Rheumatic Drugs Market Size by Type
2.3.1 Anti-Rheumatic Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Anti-Rheumatic Drugs Market Size Market Share by Type (2019-2024)
2.4 Anti-Rheumatic Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Anti-Rheumatic Drugs Market Size by Application
2.5.1 Anti-Rheumatic Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Anti-Rheumatic Drugs Market Size Market Share by Application (2019-2024)
3 ANTI-RHEUMATIC DRUGS MARKET SIZE BY PLAYER
3.1 Anti-Rheumatic Drugs Market Size Market Share by Player
3.1.1 Global Anti-Rheumatic Drugs Revenue by Player (2019-2024)
3.1.2 Global Anti-Rheumatic Drugs Revenue Market Share by Player (2019-2024)
3.2 Global Anti-Rheumatic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTI-RHEUMATIC DRUGS BY REGION
4.1 Anti-Rheumatic Drugs Market Size by Region (2019-2024)
4.2 Global Anti-Rheumatic Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Anti-Rheumatic Drugs Market Size Growth (2019-2024)
4.4 APAC Anti-Rheumatic Drugs Market Size Growth (2019-2024)
4.5 Europe Anti-Rheumatic Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa Anti-Rheumatic Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Anti-Rheumatic Drugs Market Size by Country (2019-2024)
5.2 Americas Anti-Rheumatic Drugs Market Size by Type (2019-2024)
5.3 Americas Anti-Rheumatic Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Rheumatic Drugs Market Size by Region (2019-2024)
6.2 APAC Anti-Rheumatic Drugs Market Size by Type (2019-2024)
6.3 APAC Anti-Rheumatic Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Anti-Rheumatic Drugs Market Size by Country (2019-2024)
7.2 Europe Anti-Rheumatic Drugs Market Size by Type (2019-2024)
7.3 Europe Anti-Rheumatic Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Rheumatic Drugs by Region (2019-2024)
8.2 Middle East & Africa Anti-Rheumatic Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Anti-Rheumatic Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTI-RHEUMATIC DRUGS MARKET FORECAST
10.1 Global Anti-Rheumatic Drugs Forecast by Region (2025-2030)
10.1.1 Global Anti-Rheumatic Drugs Forecast by Region (2025-2030)
10.1.2 Americas Anti-Rheumatic Drugs Forecast
10.1.3 APAC Anti-Rheumatic Drugs Forecast
10.1.4 Europe Anti-Rheumatic Drugs Forecast
10.1.5 Middle East & Africa Anti-Rheumatic Drugs Forecast
10.2 Americas Anti-Rheumatic Drugs Forecast by Country (2025-2030)
10.2.1 United States Market Anti-Rheumatic Drugs Forecast
10.2.2 Canada Market Anti-Rheumatic Drugs Forecast
10.2.3 Mexico Market Anti-Rheumatic Drugs Forecast
10.2.4 Brazil Market Anti-Rheumatic Drugs Forecast
10.3 APAC Anti-Rheumatic Drugs Forecast by Region (2025-2030)
10.3.1 China Anti-Rheumatic Drugs Market Forecast
10.3.2 Japan Market Anti-Rheumatic Drugs Forecast
10.3.3 Korea Market Anti-Rheumatic Drugs Forecast
10.3.4 Southeast Asia Market Anti-Rheumatic Drugs Forecast
10.3.5 India Market Anti-Rheumatic Drugs Forecast
10.3.6 Australia Market Anti-Rheumatic Drugs Forecast
10.4 Europe Anti-Rheumatic Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market Anti-Rheumatic Drugs Forecast
10.4.2 France Market Anti-Rheumatic Drugs Forecast
10.4.3 UK Market Anti-Rheumatic Drugs Forecast
10.4.4 Italy Market Anti-Rheumatic Drugs Forecast
10.4.5 Russia Market Anti-Rheumatic Drugs Forecast
10.5 Middle East & Africa Anti-Rheumatic Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market Anti-Rheumatic Drugs Forecast
10.5.2 South Africa Market Anti-Rheumatic Drugs Forecast
10.5.3 Israel Market Anti-Rheumatic Drugs Forecast
10.5.4 Turkey Market Anti-Rheumatic Drugs Forecast
10.6 Global Anti-Rheumatic Drugs Forecast by Type (2025-2030)
10.7 Global Anti-Rheumatic Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Anti-Rheumatic Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Anti-Rheumatic Drugs Product Offered
11.1.3 Novartis Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 UCB
11.2.1 UCB Company Information
11.2.2 UCB Anti-Rheumatic Drugs Product Offered
11.2.3 UCB Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 UCB Main Business Overview
11.2.5 UCB Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Anti-Rheumatic Drugs Product Offered
11.3.3 AbbVie Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Anti-Rheumatic Drugs Product Offered
11.4.3 Bristol-Myers Squibb Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Anti-Rheumatic Drugs Product Offered
11.5.3 Merck Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 HEYL Chemisch-pharmazeutische Fabrik
11.6.1 HEYL Chemisch-pharmazeutische Fabrik Company Information
11.6.2 HEYL Chemisch-pharmazeutische Fabrik Anti-Rheumatic Drugs Product Offered
11.6.3 HEYL Chemisch-pharmazeutische Fabrik Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 HEYL Chemisch-pharmazeutische Fabrik Main Business Overview
11.6.5 HEYL Chemisch-pharmazeutische Fabrik Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Anti-Rheumatic Drugs Product Offered
11.7.3 Roche Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Information
11.8.2 Johnson & Johnson Anti-Rheumatic Drugs Product Offered
11.8.3 Johnson & Johnson Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Johnson & Johnson Main Business Overview
11.8.5 Johnson & Johnson Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Anti-Rheumatic Drugs Product Offered
11.9.3 Amgen Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Anti-Rheumatic Drugs Product Offered
11.10.3 Pfizer Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 GSK
11.11.1 GSK Company Information
11.11.2 GSK Anti-Rheumatic Drugs Product Offered
11.11.3 GSK Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 GSK Main Business Overview
11.11.5 GSK Latest Developments
11.12 Sanofi
11.12.1 Sanofi Company Information
11.12.2 Sanofi Anti-Rheumatic Drugs Product Offered
11.12.3 Sanofi Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Sanofi Main Business Overview
11.12.5 Sanofi Latest Developments
11.13 Abbott Laboratories
11.13.1 Abbott Laboratories Company Information
11.13.2 Abbott Laboratories Anti-Rheumatic Drugs Product Offered
11.13.3 Abbott Laboratories Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Abbott Laboratories Main Business Overview
11.13.5 Abbott Laboratories Latest Developments
11.14 Teva Pharmaceutical
11.14.1 Teva Pharmaceutical Company Information
11.14.2 Teva Pharmaceutical Anti-Rheumatic Drugs Product Offered
11.14.3 Teva Pharmaceutical Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Teva Pharmaceutical Main Business Overview
11.14.5 Teva Pharmaceutical Latest Developments
11.15 Eli Lilly and Company
11.15.1 Eli Lilly and Company Company Information
11.15.2 Eli Lilly and Company Anti-Rheumatic Drugs Product Offered
11.15.3 Eli Lilly and Company Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Eli Lilly and Company Main Business Overview
11.15.5 Eli Lilly and Company Latest Developments
11.16 Celltrion
11.16.1 Celltrion Company Information
11.16.2 Celltrion Anti-Rheumatic Drugs Product Offered
11.16.3 Celltrion Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Celltrion Main Business Overview
11.16.5 Celltrion Latest Developments
11.17 Astellas Pharma
11.17.1 Astellas Pharma Company Information
11.17.2 Astellas Pharma Anti-Rheumatic Drugs Product Offered
11.17.3 Astellas Pharma Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Astellas Pharma Main Business Overview
11.17.5 Astellas Pharma Latest Developments
11.18 Simcere
11.18.1 Simcere Company Information
11.18.2 Simcere Anti-Rheumatic Drugs Product Offered
11.18.3 Simcere Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Simcere Main Business Overview
11.18.5 Simcere Latest Developments
11.19 Daiichi Sankyo
11.19.1 Daiichi Sankyo Company Information
11.19.2 Daiichi Sankyo Anti-Rheumatic Drugs Product Offered
11.19.3 Daiichi Sankyo Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Daiichi Sankyo Main Business Overview
11.19.5 Daiichi Sankyo Latest Developments
11.20 Asahi Kasei
11.20.1 Asahi Kasei Company Information
11.20.2 Asahi Kasei Anti-Rheumatic Drugs Product Offered
11.20.3 Asahi Kasei Anti-Rheumatic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Asahi Kasei Main Business Overview
11.20.5 Asahi Kasei Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-Rheumatic Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Anti-Rheumatic Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Disease Modifying Anti-rheumatics Drugs (DMARD's)
Table 4. Major Players of Nonsteroidal Anti-inflammatory Drugs (NSAID's)
Table 5. Major Players of Corticosteroids
Table 6. Major Players of Uric Acid Drugs
Table 7. Major Players of Others
Table 8. Anti-Rheumatic Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Anti-Rheumatic Drugs Market Size by Type (2019-2024) & ($ millions)
Table 10. Global Anti-Rheumatic Drugs Market Size Market Share by Type (2019-2024)
Table 11. Anti-Rheumatic Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 12. Global Anti-Rheumatic Drugs Market Size by Application (2019-2024) & ($ millions)
Table 13. Global Anti-Rheumatic Drugs Market Size Market Share by Application (2019-2024)
Table 14. Global Anti-Rheumatic Drugs Revenue by Player (2019-2024) & ($ millions)
Table 15. Global Anti-Rheumatic Drugs Revenue Market Share by Player (2019-2024)
Table 16. Anti-Rheumatic Drugs Key Players Head office and Products Offered
Table 17. Anti-Rheumatic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Anti-Rheumatic Drugs Market Size by Region (2019-2024) & ($ millions)
Table 21. Global Anti-Rheumatic Drugs Market Size Market Share by Region (2019-2024)
Table 22. Global Anti-Rheumatic Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Anti-Rheumatic Drugs Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Anti-Rheumatic Drugs Market Size by Country (2019-2024) & ($ millions)
Table 25. Americas Anti-Rheumatic Drugs Market Size Market Share by Country (2019-2024)
Table 26. Americas Anti-Rheumatic Drugs Market Size by Type (2019-2024) & ($ millions)
Table 27. Americas Anti-Rheumatic Drugs Market Size Market Share by Type (2019-2024)
Table 28. Americas Anti-Rheumatic Drugs Market Size by Application (2019-2024) & ($ millions)
Table 29. Americas Anti-Rheumatic Drugs Market Size Market Share by Application (2019-2024)
Table 30. APAC Anti-Rheumatic Drugs Market Size by Region (2019-2024) & ($ millions)
Table 31. APAC Anti-Rheumatic Drugs Market Size Market Share by Region (2019-2024)
Table 32. APAC Anti-Rheumatic Drugs Market Size by Type (2019-2024) & ($ millions)
Table 33. APAC Anti-Rheumatic Drugs Market Size by Application (2019-2024) & ($ millions)
Table 34. Europe Anti-Rheumatic Drugs Market Size by Country (2019-2024) & ($ millions)
Table 35. Europe Anti-Rheumatic Drugs Market Size Market Share by Country (2019-2024)
Table 36. Europe Anti-Rheumatic Drugs Market Size by Type (2019-2024) & ($ millions)
Table 37. Europe Anti-Rheumatic Drugs Market Size by Application (2019-2024) & ($ millions)
Table 38. Middle East & Africa Anti-Rheumatic Drugs Market Size by Region (2019-2024) & ($ millions)
Table 39. Middle East & Africa Anti-Rheumatic Drugs Market Size by Type (2019-2024) & ($ millions)
Table 40. Middle East & Africa Anti-Rheumatic Drugs Market Size by Application (2019-2024) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Anti-Rheumatic Drugs
Table 42. Key Market Challenges & Risks of Anti-Rheumatic Drugs
Table 43. Key Industry Trends of Anti-Rheumatic Drugs
Table 44. Global Anti-Rheumatic Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 45. Global Anti-Rheumatic Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 46. Global Anti-Rheumatic Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 47. Global Anti-Rheumatic Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 48. Novartis Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 49. Novartis Anti-Rheumatic Drugs Product Offered
Table 50. Novartis Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 51. Novartis Main Business
Table 52. Novartis Latest Developments
Table 53. UCB Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 54. UCB Anti-Rheumatic Drugs Product Offered
Table 55. UCB Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. UCB Main Business
Table 57. UCB Latest Developments
Table 58. AbbVie Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 59. AbbVie Anti-Rheumatic Drugs Product Offered
Table 60. AbbVie Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. AbbVie Main Business
Table 62. AbbVie Latest Developments
Table 63. Bristol-Myers Squibb Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 64. Bristol-Myers Squibb Anti-Rheumatic Drugs Product Offered
Table 65. Bristol-Myers Squibb Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Bristol-Myers Squibb Main Business
Table 67. Bristol-Myers Squibb Latest Developments
Table 68. Merck Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 69. Merck Anti-Rheumatic Drugs Product Offered
Table 70. Merck Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Merck Main Business
Table 72. Merck Latest Developments
Table 73. HEYL Chemisch-pharmazeutische Fabrik Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 74. HEYL Chemisch-pharmazeutische Fabrik Anti-Rheumatic Drugs Product Offered
Table 75. HEYL Chemisch-pharmazeutische Fabrik Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. HEYL Chemisch-pharmazeutische Fabrik Main Business
Table 77. HEYL Chemisch-pharmazeutische Fabrik Latest Developments
Table 78. Roche Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 79. Roche Anti-Rheumatic Drugs Product Offered
Table 80. Roche Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Roche Main Business
Table 82. Roche Latest Developments
Table 83. Johnson & Johnson Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 84. Johnson & Johnson Anti-Rheumatic Drugs Product Offered
Table 85. Johnson & Johnson Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Latest Developments
Table 88. Amgen Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 89. Amgen Anti-Rheumatic Drugs Product Offered
Table 90. Amgen Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Amgen Main Business
Table 92. Amgen Latest Developments
Table 93. Pfizer Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 94. Pfizer Anti-Rheumatic Drugs Product Offered
Table 95. Pfizer Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. GSK Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 99. GSK Anti-Rheumatic Drugs Product Offered
Table 100. GSK Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. GSK Main Business
Table 102. GSK Latest Developments
Table 103. Sanofi Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 104. Sanofi Anti-Rheumatic Drugs Product Offered
Table 105. Sanofi Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Sanofi Main Business
Table 107. Sanofi Latest Developments
Table 108. Abbott Laboratories Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 109. Abbott Laboratories Anti-Rheumatic Drugs Product Offered
Table 110. Abbott Laboratories Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Abbott Laboratories Main Business
Table 112. Abbott Laboratories Latest Developments
Table 113. Teva Pharmaceutical Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 114. Teva Pharmaceutical Anti-Rheumatic Drugs Product Offered
Table 115. Teva Pharmaceutical Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Teva Pharmaceutical Main Business
Table 117. Teva Pharmaceutical Latest Developments
Table 118. Eli Lilly and Company Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 119. Eli Lilly and Company Anti-Rheumatic Drugs Product Offered
Table 120. Eli Lilly and Company Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Eli Lilly and Company Main Business
Table 122. Eli Lilly and Company Latest Developments
Table 123. Celltrion Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 124. Celltrion Anti-Rheumatic Drugs Product Offered
Table 125. Celltrion Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Celltrion Main Business
Table 127. Celltrion Latest Developments
Table 128. Astellas Pharma Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 129. Astellas Pharma Anti-Rheumatic Drugs Product Offered
Table 130. Astellas Pharma Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Astellas Pharma Main Business
Table 132. Astellas Pharma Latest Developments
Table 133. Simcere Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 134. Simcere Anti-Rheumatic Drugs Product Offered
Table 135. Simcere Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Simcere Main Business
Table 137. Simcere Latest Developments
Table 138. Daiichi Sankyo Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 139. Daiichi Sankyo Anti-Rheumatic Drugs Product Offered
Table 140. Daiichi Sankyo Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Daiichi Sankyo Main Business
Table 142. Daiichi Sankyo Latest Developments
Table 143. Asahi Kasei Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 144. Asahi Kasei Anti-Rheumatic Drugs Product Offered
Table 145. Asahi Kasei Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. Asahi Kasei Main Business
Table 147. Asahi Kasei Latest Developments
Table 1. Anti-Rheumatic Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Anti-Rheumatic Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Disease Modifying Anti-rheumatics Drugs (DMARD's)
Table 4. Major Players of Nonsteroidal Anti-inflammatory Drugs (NSAID's)
Table 5. Major Players of Corticosteroids
Table 6. Major Players of Uric Acid Drugs
Table 7. Major Players of Others
Table 8. Anti-Rheumatic Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Anti-Rheumatic Drugs Market Size by Type (2019-2024) & ($ millions)
Table 10. Global Anti-Rheumatic Drugs Market Size Market Share by Type (2019-2024)
Table 11. Anti-Rheumatic Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 12. Global Anti-Rheumatic Drugs Market Size by Application (2019-2024) & ($ millions)
Table 13. Global Anti-Rheumatic Drugs Market Size Market Share by Application (2019-2024)
Table 14. Global Anti-Rheumatic Drugs Revenue by Player (2019-2024) & ($ millions)
Table 15. Global Anti-Rheumatic Drugs Revenue Market Share by Player (2019-2024)
Table 16. Anti-Rheumatic Drugs Key Players Head office and Products Offered
Table 17. Anti-Rheumatic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Anti-Rheumatic Drugs Market Size by Region (2019-2024) & ($ millions)
Table 21. Global Anti-Rheumatic Drugs Market Size Market Share by Region (2019-2024)
Table 22. Global Anti-Rheumatic Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Anti-Rheumatic Drugs Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Anti-Rheumatic Drugs Market Size by Country (2019-2024) & ($ millions)
Table 25. Americas Anti-Rheumatic Drugs Market Size Market Share by Country (2019-2024)
Table 26. Americas Anti-Rheumatic Drugs Market Size by Type (2019-2024) & ($ millions)
Table 27. Americas Anti-Rheumatic Drugs Market Size Market Share by Type (2019-2024)
Table 28. Americas Anti-Rheumatic Drugs Market Size by Application (2019-2024) & ($ millions)
Table 29. Americas Anti-Rheumatic Drugs Market Size Market Share by Application (2019-2024)
Table 30. APAC Anti-Rheumatic Drugs Market Size by Region (2019-2024) & ($ millions)
Table 31. APAC Anti-Rheumatic Drugs Market Size Market Share by Region (2019-2024)
Table 32. APAC Anti-Rheumatic Drugs Market Size by Type (2019-2024) & ($ millions)
Table 33. APAC Anti-Rheumatic Drugs Market Size by Application (2019-2024) & ($ millions)
Table 34. Europe Anti-Rheumatic Drugs Market Size by Country (2019-2024) & ($ millions)
Table 35. Europe Anti-Rheumatic Drugs Market Size Market Share by Country (2019-2024)
Table 36. Europe Anti-Rheumatic Drugs Market Size by Type (2019-2024) & ($ millions)
Table 37. Europe Anti-Rheumatic Drugs Market Size by Application (2019-2024) & ($ millions)
Table 38. Middle East & Africa Anti-Rheumatic Drugs Market Size by Region (2019-2024) & ($ millions)
Table 39. Middle East & Africa Anti-Rheumatic Drugs Market Size by Type (2019-2024) & ($ millions)
Table 40. Middle East & Africa Anti-Rheumatic Drugs Market Size by Application (2019-2024) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Anti-Rheumatic Drugs
Table 42. Key Market Challenges & Risks of Anti-Rheumatic Drugs
Table 43. Key Industry Trends of Anti-Rheumatic Drugs
Table 44. Global Anti-Rheumatic Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 45. Global Anti-Rheumatic Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 46. Global Anti-Rheumatic Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 47. Global Anti-Rheumatic Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 48. Novartis Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 49. Novartis Anti-Rheumatic Drugs Product Offered
Table 50. Novartis Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 51. Novartis Main Business
Table 52. Novartis Latest Developments
Table 53. UCB Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 54. UCB Anti-Rheumatic Drugs Product Offered
Table 55. UCB Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. UCB Main Business
Table 57. UCB Latest Developments
Table 58. AbbVie Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 59. AbbVie Anti-Rheumatic Drugs Product Offered
Table 60. AbbVie Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. AbbVie Main Business
Table 62. AbbVie Latest Developments
Table 63. Bristol-Myers Squibb Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 64. Bristol-Myers Squibb Anti-Rheumatic Drugs Product Offered
Table 65. Bristol-Myers Squibb Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Bristol-Myers Squibb Main Business
Table 67. Bristol-Myers Squibb Latest Developments
Table 68. Merck Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 69. Merck Anti-Rheumatic Drugs Product Offered
Table 70. Merck Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Merck Main Business
Table 72. Merck Latest Developments
Table 73. HEYL Chemisch-pharmazeutische Fabrik Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 74. HEYL Chemisch-pharmazeutische Fabrik Anti-Rheumatic Drugs Product Offered
Table 75. HEYL Chemisch-pharmazeutische Fabrik Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. HEYL Chemisch-pharmazeutische Fabrik Main Business
Table 77. HEYL Chemisch-pharmazeutische Fabrik Latest Developments
Table 78. Roche Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 79. Roche Anti-Rheumatic Drugs Product Offered
Table 80. Roche Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Roche Main Business
Table 82. Roche Latest Developments
Table 83. Johnson & Johnson Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 84. Johnson & Johnson Anti-Rheumatic Drugs Product Offered
Table 85. Johnson & Johnson Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Latest Developments
Table 88. Amgen Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 89. Amgen Anti-Rheumatic Drugs Product Offered
Table 90. Amgen Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Amgen Main Business
Table 92. Amgen Latest Developments
Table 93. Pfizer Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 94. Pfizer Anti-Rheumatic Drugs Product Offered
Table 95. Pfizer Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. GSK Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 99. GSK Anti-Rheumatic Drugs Product Offered
Table 100. GSK Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. GSK Main Business
Table 102. GSK Latest Developments
Table 103. Sanofi Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 104. Sanofi Anti-Rheumatic Drugs Product Offered
Table 105. Sanofi Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Sanofi Main Business
Table 107. Sanofi Latest Developments
Table 108. Abbott Laboratories Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 109. Abbott Laboratories Anti-Rheumatic Drugs Product Offered
Table 110. Abbott Laboratories Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Abbott Laboratories Main Business
Table 112. Abbott Laboratories Latest Developments
Table 113. Teva Pharmaceutical Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 114. Teva Pharmaceutical Anti-Rheumatic Drugs Product Offered
Table 115. Teva Pharmaceutical Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Teva Pharmaceutical Main Business
Table 117. Teva Pharmaceutical Latest Developments
Table 118. Eli Lilly and Company Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 119. Eli Lilly and Company Anti-Rheumatic Drugs Product Offered
Table 120. Eli Lilly and Company Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Eli Lilly and Company Main Business
Table 122. Eli Lilly and Company Latest Developments
Table 123. Celltrion Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 124. Celltrion Anti-Rheumatic Drugs Product Offered
Table 125. Celltrion Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Celltrion Main Business
Table 127. Celltrion Latest Developments
Table 128. Astellas Pharma Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 129. Astellas Pharma Anti-Rheumatic Drugs Product Offered
Table 130. Astellas Pharma Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Astellas Pharma Main Business
Table 132. Astellas Pharma Latest Developments
Table 133. Simcere Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 134. Simcere Anti-Rheumatic Drugs Product Offered
Table 135. Simcere Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Simcere Main Business
Table 137. Simcere Latest Developments
Table 138. Daiichi Sankyo Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 139. Daiichi Sankyo Anti-Rheumatic Drugs Product Offered
Table 140. Daiichi Sankyo Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Daiichi Sankyo Main Business
Table 142. Daiichi Sankyo Latest Developments
Table 143. Asahi Kasei Details, Company Type, Anti-Rheumatic Drugs Area Served and Its Competitors
Table 144. Asahi Kasei Anti-Rheumatic Drugs Product Offered
Table 145. Asahi Kasei Anti-Rheumatic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. Asahi Kasei Main Business
Table 147. Asahi Kasei Latest Developments
LIST OF FIGURES
Figure 1. Anti-Rheumatic Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-Rheumatic Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Anti-Rheumatic Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Anti-Rheumatic Drugs Sales Market Share by Country/Region (2023)
Figure 8. Anti-Rheumatic Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Anti-Rheumatic Drugs Market Size Market Share by Type in 2023
Figure 10. Anti-Rheumatic Drugs in Hospital Pharmacies
Figure 11. Global Anti-Rheumatic Drugs Market: Hospital Pharmacies (2019-2024) & ($ millions)
Figure 12. Anti-Rheumatic Drugs in Retail Pharmacies
Figure 13. Global Anti-Rheumatic Drugs Market: Retail Pharmacies (2019-2024) & ($ millions)
Figure 14. Anti-Rheumatic Drugs in Online Pharmacies
Figure 15. Global Anti-Rheumatic Drugs Market: Online Pharmacies (2019-2024) & ($ millions)
Figure 16. Global Anti-Rheumatic Drugs Market Size Market Share by Application in 2023
Figure 17. Global Anti-Rheumatic Drugs Revenue Market Share by Player in 2023
Figure 18. Global Anti-Rheumatic Drugs Market Size Market Share by Region (2019-2024)
Figure 19. Americas Anti-Rheumatic Drugs Market Size 2019-2024 ($ millions)
Figure 20. APAC Anti-Rheumatic Drugs Market Size 2019-2024 ($ millions)
Figure 21. Europe Anti-Rheumatic Drugs Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Anti-Rheumatic Drugs Market Size 2019-2024 ($ millions)
Figure 23. Americas Anti-Rheumatic Drugs Value Market Share by Country in 2023
Figure 24. United States Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Anti-Rheumatic Drugs Market Size Market Share by Region in 2023
Figure 29. APAC Anti-Rheumatic Drugs Market Size Market Share by Type (2019-2024)
Figure 30. APAC Anti-Rheumatic Drugs Market Size Market Share by Application (2019-2024)
Figure 31. China Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. India Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Anti-Rheumatic Drugs Market Size Market Share by Country in 2023
Figure 38. Europe Anti-Rheumatic Drugs Market Size Market Share by Type (2019-2024)
Figure 39. Europe Anti-Rheumatic Drugs Market Size Market Share by Application (2019-2024)
Figure 40. Germany Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 41. France Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Anti-Rheumatic Drugs Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Anti-Rheumatic Drugs Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Anti-Rheumatic Drugs Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 54. APAC Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 55. Europe Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 57. United States Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 58. Canada Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 59. Mexico Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 60. Brazil Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 61. China Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 62. Japan Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 63. Korea Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 65. India Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 66. Australia Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 67. Germany Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 68. France Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 69. UK Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 70. Italy Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 71. Russia Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 72. Egypt Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 73. South Africa Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 74. Israel Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 75. Turkey Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 77. Global Anti-Rheumatic Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Anti-Rheumatic Drugs Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Anti-Rheumatic Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-Rheumatic Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Anti-Rheumatic Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Anti-Rheumatic Drugs Sales Market Share by Country/Region (2023)
Figure 8. Anti-Rheumatic Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Anti-Rheumatic Drugs Market Size Market Share by Type in 2023
Figure 10. Anti-Rheumatic Drugs in Hospital Pharmacies
Figure 11. Global Anti-Rheumatic Drugs Market: Hospital Pharmacies (2019-2024) & ($ millions)
Figure 12. Anti-Rheumatic Drugs in Retail Pharmacies
Figure 13. Global Anti-Rheumatic Drugs Market: Retail Pharmacies (2019-2024) & ($ millions)
Figure 14. Anti-Rheumatic Drugs in Online Pharmacies
Figure 15. Global Anti-Rheumatic Drugs Market: Online Pharmacies (2019-2024) & ($ millions)
Figure 16. Global Anti-Rheumatic Drugs Market Size Market Share by Application in 2023
Figure 17. Global Anti-Rheumatic Drugs Revenue Market Share by Player in 2023
Figure 18. Global Anti-Rheumatic Drugs Market Size Market Share by Region (2019-2024)
Figure 19. Americas Anti-Rheumatic Drugs Market Size 2019-2024 ($ millions)
Figure 20. APAC Anti-Rheumatic Drugs Market Size 2019-2024 ($ millions)
Figure 21. Europe Anti-Rheumatic Drugs Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Anti-Rheumatic Drugs Market Size 2019-2024 ($ millions)
Figure 23. Americas Anti-Rheumatic Drugs Value Market Share by Country in 2023
Figure 24. United States Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Anti-Rheumatic Drugs Market Size Market Share by Region in 2023
Figure 29. APAC Anti-Rheumatic Drugs Market Size Market Share by Type (2019-2024)
Figure 30. APAC Anti-Rheumatic Drugs Market Size Market Share by Application (2019-2024)
Figure 31. China Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. India Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Anti-Rheumatic Drugs Market Size Market Share by Country in 2023
Figure 38. Europe Anti-Rheumatic Drugs Market Size Market Share by Type (2019-2024)
Figure 39. Europe Anti-Rheumatic Drugs Market Size Market Share by Application (2019-2024)
Figure 40. Germany Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 41. France Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Anti-Rheumatic Drugs Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Anti-Rheumatic Drugs Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Anti-Rheumatic Drugs Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Anti-Rheumatic Drugs Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 54. APAC Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 55. Europe Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 57. United States Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 58. Canada Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 59. Mexico Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 60. Brazil Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 61. China Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 62. Japan Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 63. Korea Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 65. India Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 66. Australia Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 67. Germany Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 68. France Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 69. UK Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 70. Italy Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 71. Russia Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 72. Egypt Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 73. South Africa Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 74. Israel Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 75. Turkey Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Anti-Rheumatic Drugs Market Size 2025-2030 ($ millions)
Figure 77. Global Anti-Rheumatic Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Anti-Rheumatic Drugs Market Size Market Share Forecast by Application (2025-2030)
